Marco Giallombardo

Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells.

Nintedanib in non-small cell lung cancer: from preclinical to approval.

Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.

Reduction in mdx mouse muscle degeneration by low-intensity endurance exercise: a proteomic analysis in quadriceps muscle of exercised compared with sedentary mdx mice.

Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.

In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.

The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer.

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.